Abstract:Hepatitis C virus (HCV) infection is one of the major factors to trigger a sustained hepatic inflammatory response and hence hepatocellular carcinoma (HCC), but direct-acting-antiviral (DAAs) was not efficient to suppress HCC development. Heat shock protein 90 kDa (HSP90) is highly abundant in different types of cancers, and especially controls protein translation, endoplasmic reticulum stress, and viral replication. In this study we investigated the correlation between the expression levels of HSP90 isoforms and inflammatory response marker NLRP3 in different types of HCC patients as well as the effect of a natural product celastrol in suppression of HCV translation and associated inflammatory response in vivo. We identified that the expression level of HSP90β isoform was correlated with that of NLRP3 in the liver tissues of HCV positive HCC patients ( R 2 = 0.3867, P < 0.0101), but not in hepatitis B virus-associated HCC or cirrhosis patients. We demonstrated that celastrol (3, 10, 30 μM) dose-dependently suppressed the ATPase activity of both HSP90α and HSP90β, while its anti-HCV activity was dependent on the Ala47 residue in the ATPase pocket of HSP90β. Celastrol (200 nM) halted HCV internal ribosomal entry site (IRES)-mediated translation at the initial step by disrupting the association between HSP90β and 4EBP1. The inhibitory activity of celastrol on HCV RNA-dependent RNA polymerase (RdRp)-triggered inflammatory response also depended on the Ala47 residue of HSP90β. Intravenous injection of adenovirus expressing HCV NS5B (pAde-NS5B) in mice induced severe hepatic inflammatory response characterized by significantly increased infiltration of immune cells and hepatic expression level of Nlrp3, which was dose-dependently ameliorated by pretreatment with celastrol (0.2, 0.5 mg/kg, i.p.). This study reveals a fundamental role of HSP90β in governing HCV IRES-mediated translation as well as hepatic inflammation, and celastrol as a novel inhibitor of HCV translation and associated inflammation by specifically targeting HSP90β, which could be developed as a lead for the treatment of HSP90β positive HCV-associated HCC.

Small Molecular Compounds That Inhibit Hepatitis C Virus Replication Through Destabilizing Heat Shock Cognate 70 Messenger RNA.

Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus

Anti-HBV Efficacy of Combined Sirnas Targeting Viral Gene and Heat Shock Cognate 70

Host Apolipoprotein B Messenger RNA-editing Enzyme Catalytic Polypeptide-Like 3G is an Innate Defensive Factor and Drug Target Against Hepatitis C Virus

Inhibition of Hepatitis C Virus Replication and Expression by Small Interfering Rna Targeting Host Cellular Genes

The Novel Compound Z060228 Inhibits Assembly of the HBV Capsid.

A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor

Downregulation of hepatitis C virus replication by miR-196a using lentiviral vectors

Direct Imaging of the Disruption of Hepatitis C Virus Replication Complexes by Inhibitors of Lipid Metabolism

Inhibitors of Endoplasmic Reticulum Α-Glucosidases Potently Suppress Hepatitis C Virus Virion Assembly and Release

Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot

Celastrol attenuates hepatitis C virus translation and inflammatory response in mice by suppressing heat shock protein 90β

Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription

Structure-based virtual screening of natural compounds as inhibitors of HCV using molecular docking and molecular dynamics simulation studies

A Novel Strategy to Inhibit the Reproduction and Translation of Hepatitis C Virus

Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme

Interferon-Stimulated SAMHD1 Restricts Hepatitis C Virus Replication

RNA Interference Effectively Inhibits Mrna Accumulation and Protein Expression of Hepatitis C Virus Core and E2 Genes in Human Cells

A novel small molecule inhibitor of hepatitis C virus entry

Establishment and Application of A High Throughput Screening System Targeting the Interaction Between Hcv Internal Ribosome Entry Site and Human Eukaryotic Translation Initiation Factor 3

Inhibition of Hepatitis C Virus Replication by GS-6620, a Potent C -Nucleoside Monophosphate Prodrug